Robin Mansukhani - CEO of Deciduous Therapeutics - Immunotherapy

from Life Science Success · host Don Davis PhD, MBA

Send us Fan MailIn this episode of the Life Science Success Podcast my guest is Robin Mansukhani. Robin is the CEO of Deciduous Therapeutics, a venture backed startup developing novel immunotherapies to treat age-related diseases. Additionally, he co-founded BlueStamp Engineering, an intensive, project-based engineering program for high school students in NYC, San Francisco, and Palo Alto.

Episode metadata supplied by the publisher feed · Published Dec 17, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Robin Mansukhani - CEO of Deciduous Therapeutics - Immunotherapy

0:00 27:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Life Science Success?

This episode is 27 minutes long.

When was this Life Science Success episode published?

This episode was published on December 17, 2022.

Can I download this Life Science Success episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!